Düsseldorf Bread Study
DBS
1 other identifier
interventional
80
1 country
1
Brief Summary
The hypothesis is to be tested that eating carbohydrate-reduced bread over three months leads to a significant weight difference compared to conventional, carbohydrate-rich bread.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2020
CompletedFirst Posted
Study publicly available on registry
January 30, 2020
CompletedStudy Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2021
CompletedOctober 28, 2021
October 1, 2021
1.2 years
January 22, 2020
October 27, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
body weight
change of body weight in kg
3 months
Secondary Outcomes (14)
body mass index
3 months
waist circumference
3 months
waist-to-height-index
3 months
hip circumference
3 months
blood pressure
3 months
- +9 more secondary outcomes
Study Arms (2)
carbohydrate rich bread
PLACEBO COMPARATORcarbohydrate reduced bread
EXPERIMENTALInterventions
Consumption of carbohydrate reduced bread for three months.
Consumption of carbohydrate rich bread for three months.
Eligibility Criteria
You may qualify if:
- \- body mass index of at least 27 kg/m2
You may not qualify if:
- serious illness with hospitalization in the last 3 months
- Changes in body weight (estimated weekly average) by more than 2 kg in the past 4 weeks
- Non-smoking status for less than 3 months
- Change of smoking habits planned during the study
- acute diseases such as respiratory or gastrointestinal infections
- Chronic diseases, e.g. Tumor diseases, chronic obstructive pulmonary disease (COPD), asthma, dementia, intestinal diseases, diabetes
- regular use of medication (except contraceptives) such as Lipid lowering, blood pressure lowering, weight-regulating medication, aspirin
- no contraception in women of childbearing age or breastfeeding a child
- high sporting activity (≥ 1 hour per day)
- planned absence of\> 7 days during the intervention phase
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- West German Center of Diabetes and Healthlead
- Bakery Hinkelcollaborator
Study Sites (1)
West German Centre of Diabetes and Health
Düsseldorf, 40591, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- director
Study Record Dates
First Submitted
January 22, 2020
First Posted
January 30, 2020
Study Start
August 1, 2020
Primary Completion
October 21, 2021
Study Completion
October 21, 2021
Last Updated
October 28, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share